Blood Proteins Could Hold Key To Accurately Identifying Onset Of Condition

Scientists have revealed that a set of proteins could hold the key to being able to predict the potential onset of dementia and Alzheimer’s disease.

In findings published in the Alzheimer’s and Dementia journal, it has been revealed that particularly proteins can be used to predict whether someone is set to suffer from the illness with an accuracy of around 87 per cent.

The research, carried out by both university and industry scientists, analysed differences in the blood of health people, those with mild cognitive impairment and others with Alzheimer’s disease.

Through such work, they could identify which of those with mild cognitive impairment would go on to develop Alzheimer’s disease. The BBC reports that such findings could be used to aid the development of further drugs for the treatment of the condition.

Expert Opinion

Any step forward in the development of a better understanding of Alzheimer’s has to be welcomed, as the condition affects a vast number of people globally. <br/> <br/>"A condition of this nature is just one of the reasons why we always advise that people ensure they have planned for the future, as developing such conditions without having wills or lasting power of attorneys in place can have a significant impact on friends and family – leaving them uncertain of a person’s wishes regarding their estate. <br/> <br/>"Through our work, we have seen numerous examples when families have been ripped apart by disputes regarding a loved one’s assets or what care they should receive. By seeking legal advice, people can ensure that they put plans in place which will ensure that families are left in no doubt regarding their wishes. <br/> <br/>"It is clear that further developments in treating dementia and Alzheimer’s disease remain far off, so we would urge people to put this issue on their agenda and spare their loved ones potentially time-consuming and costly legal battles."